{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:49:20Z","timestamp":1760708960102},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573498"],"award-info":[{"award-number":["81573498"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jchromb.2015.12.001","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T16:45:20Z","timestamp":1449074720000},"page":"219-224","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development of a sensitive enzyme-linked immunosorbent assay for the measurement of biologically active etanercept in patients with ankylosing spondylitis"],"prefix":"10.1016","volume":"1008","author":[{"given":"Lei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeneng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2015.12.001_bib0005","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2165\/00003495-200767080-00011","article-title":"Etanercept","volume":"67","author":"Dhillon","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.jchromb.2015.12.001_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta15140","article-title":"Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation","volume":"15","author":"Malottki","year":"2011","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0015","first-page":"90","article-title":"Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action","volume":"47","author":"Feldmann","year":"1994","journal-title":"J. Inflamm."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/628748","article-title":"Targeting TNF and its family members in autoimmune\/inflammatory disease","volume":"2014","author":"Desplat-J\u00e9go","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0025","first-page":"1","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"0","author":"Smolen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0030","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/annrheumdis-2013-204128","article-title":"Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab","volume":"74","author":"Neovius","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0035","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12026-014-8542-z","article-title":"Complement in monoclonal antibody therapy of cancer","volume":"59","author":"Rogers","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0045","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti\u2013interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0050","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/FTD.0b013e3181ef582a","article-title":"An enzyme-linked immunosorbent assay to study bevacizumab pharmacokinetics","volume":"32","author":"Ternant","year":"2010","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0055","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1211\/jpp.57.11.0005","article-title":"The pharmacokinetics of etanercept in patients with end\u2010stage renal disease on haemodialysis","volume":"57","author":"Don","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0060","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/0091270006286435","article-title":"The comparability of etanercept pharmacokinetics in healthy Japanese and American subjects","volume":"46","author":"Kawai","year":"2006","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0065","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s11095-011-0396-7","article-title":"Pharmacokinetic-pharmacodynamic disease progression model for effect of etanercept in Lewis rats with collagen-induced arthritis","volume":"28","author":"Lon","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/0091270004273321","article-title":"Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein","volume":"45","author":"Zhou","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0075","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1039\/C5AN00364D","article-title":"A microfluidic immunoassay platform for the detection of free prostate specific antigen: a systematic and quantitative approach","volume":"140","author":"Madaboosi","year":"2015","journal-title":"Analyst."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0080","first-page":"1","article-title":"ELISA. Theory and practice","volume":"42","author":"Crowther","year":"1995","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0085","first-page":"1","article-title":"The ELISA guidebook","volume":"149","author":"Crowther","year":"2000","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0090","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1023\/B:PHAM.0000003390.51761.3d","article-title":"Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules","volume":"20","author":"DeSilva","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1208\/s12248-011-9251-3","article-title":"Bioanalytical approaches to quantify total and free therapeutic antibodies and their targets: technical challenges and PK\/PD applications over the course of drug development","volume":"13","author":"Lee","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0100","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/aps.2010.113","article-title":"Population pharmacokinetics of rhTNFR-Fc in healthy Chinese volunteers and in Chinese patients with Ankylosing spondylitis","volume":"31","author":"Fang","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jchromb.2015.12.001_bib0105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2133.2006.07585.x","article-title":"Comparison of clinical and pharmacokinetic profiles of etanercept 25mg twice weekly and 50mg once weekly in patients with psoriasis","volume":"156","author":"Elewski","year":"2007","journal-title":"Br. J. Dermatol."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023215303251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023215303251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T07:21:38Z","timestamp":1537168898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023215303251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":21,"alternative-id":["S1570023215303251"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2015.12.001","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a sensitive enzyme-linked immunosorbent assay for the measurement of biologically active etanercept in patients with ankylosing spondylitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2015.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}